CCL5 overexpression
|
Small Cell Lung Cancer
|
CCL5 overexpression
|
Small Cell Lung Cancer
|
olaparib Sensitive: C3 – Early Trials
|
olaparib Sensitive: C3 – Early Trials
|
CCL5 overexpression
|
Small Cell Lung Cancer
|
CCL5 overexpression
|
Small Cell Lung Cancer
|
durvalumab Sensitive: C3 – Early Trials
|
durvalumab Sensitive: C3 – Early Trials
|
CCL5 overexpression
|
GBM
|
CCL5 overexpression
|
GBM
|
maraviroc Sensitive: D – Preclinical
|
maraviroc Sensitive: D – Preclinical
|